Key Statistics: XPH

SPDR S&P PHARMACEUTICALS

115.51down-0.96 (-0.82%)

 as of 2:50:02pm ET 09/03/2015

Basic Facts

ETP Type Exchange Traded Fund Sponsor SSGA Funds Management, Inc / SPDRs
Legal Structure Open-End Investment Company Inception Date 06/19/2006
Schedule K-1 No Options Yes
Leveraged No Management Team 3 Managers
Inverse No

Management Team

Michael Feehily

Tenure: 3 years 9 months

Click to expand.Show Bio

Karl Schneider

Tenure: 9 months

Click to expand.Show Bio

John Tucker

Tenure: 9 years 1 month

Click to expand.Show Bio

Portfolio Fundamentals

Valuation Info XPH Asset Class Median Percentile in Asset Class
Tracking Error 0.09 0.47
85th
Annual Turnover Ratio 68.00% 18.00%
14th
Efficiency 0.44 0.02
65th
Concentration Risk 8.13 10.10
62nd
Tax Cost Ratio 1.87% 0.73%
10th
Equity: Price/Trailing Earnings 31.29 17.61
2nd
Equity: Price/Book 4.91 1.98
5th
Equity: Price/Sales 5.38 1.29
2nd
Equity: Price/Cash Flow 25.60 9.65
1st
30-day SEC Yield
AS OF 08/28/2015
0.34% 1.81%
7th
Dividend Yield (Annualized) 0.72% n/a n/a
Net Expense Ratio 0.35% 0.55%
80th
Total Expense Ratio Reported 0.35% 0.60%
82nd
Equity: Historical Earnings Growth % -- +9.85%
--
Equity: Sales Growth % +6.27% +2.60%
78th
Equity: Cash Flow Growth % +2.01% +3.97%
38th
Equity: Book-Value Growth % +18.68% +5.04%
100th
Net Assets $1.2B $100.0M
85th

Trading Statistics

Valuation Info XPH Asset Class Median Percentile in Asset Class
Average Monthly Bid/Ask Ratio 0.10% 0.16%
68th
Premium/Discount (1 Month Rolling Average) 0.00% 0.01%
--
Premium/Discount (1 Year Average) 0.02% 0.02%
79th
Volume 88.5K 26.6K
70th
Volume (Today/Avg 10 Day) 0.5 0.5
74th
Volume (10 Day Average) 162.4K 41.4K
69th
Volume (30 Day Average) 114.1K 30.2K
68th
Volume (90 Day Average) 81.8K 29.3K
65th
Volume (10 Day Avg/90 Day Avg) 2.0 1.7
67th
Shares Outstanding 8.7M 3.0M
71st
Short as a % of Shares Outstanding 4.86% 0.62%
16th
Days to Cover 6.63 0.84
7th
% Change in Short Interest (from previous month) -4.29% -11.44%
44th
* Shares Short and Short Interest data provided by NASDAQ, NYSE or AMEX and is updated periodically and on a bi-monthly basis (depending on the listing exchange).
Free commission offer applies to online purchases of Fidelity ETFs and select iShares ETFs in a Fidelity brokerage account. Fidelity accounts may require minimum balances. The sale of ETFs is subject to an activity assessment fee (of between $0.01 to $0.03 per $1,000 of principal). iShares ETFs and Fidelity ETFs are subject to a short-term trading fee by Fidelity if held less than 30 days. The performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. Click on the "Performance & Risk" link to view quarter-end performance.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive, long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Additional information about the sources, amounts, and terms of compensation is described in the ETFs prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.